StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Citi Reiterates Buy Rating on Johnson & Johnson (JNJ)
October 15, 2024 8:20 AM
Citi analyst Joanna Wuensch reiterated a Buy rating and $180.00 price target on Johnson & Johnson (NYSE: JNJ).The analyst comments ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Johnson & Johnson (JNJ) PT Raised to $181 at RBC Capital
October 16, 2024 6:50 AM
Johnson & Johnson (JNJ) PT Raised to $170 at Stifel
October 15, 2024 2:22 PM
Johnson & Johnson (JNJ) demonstrates sustained disease control in adolescents living with generalized myasthenia gravis in Phase 2/3 study
October 15, 2024 8:01 AM
Nipocalimab demonstrates sustained disease control in adolescents living with generalized myasthenia gravis in Phase 2/3 study
October 15, 2024 8:00 AM
Form 8-K JOHNSON & JOHNSON For: Oct 15
October 15, 2024 7:38 AM
Johnson&Johnson reports Q3 beat, raises sales guidance
October 15, 2024 7:04 AM
Johnson & Johnson (JNJ) Declares $1.24 Quarterly Dividend; 3.1% Yield
October 15, 2024 6:25 AM
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2024
October 15, 2024 6:25 AM
Cancer drug sales lift J&J past Wall Street expectations
October 15, 2024 6:22 AM
Johnson & Johnson (JNJ) Tops Q3 EPS by 23c, Beats on Revenue
October 15, 2024 6:22 AM
Johnson & Johnson Reports Q3 2024 Results
October 15, 2024 6:20 AM
Johnson & Johnson reports earnings ahead of the open. Here's what to know
October 15, 2024 3:00 AM
Johnson & Johnson (JNJ) October option implied volatility into quarter results
October 14, 2024 11:14 AM
Johnson & Johnson (JNJ) October 160 straddle priced into quarter results
October 14, 2024 3:55 AM
Johnson & Johnson (JNJ) October 160 straddle priced into quarter results
October 11, 2024 4:23 AM
